Related Experiment Video
Updated: Feb 13, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Stimuli-Responsive NO Release for On-Demand Gas-Sensitized Synergistic Cancer Therapy
Wenpei Fan1, Bryant C Yung1, Xiaoyuan Chen1
1Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Featuring high biocompatibility, the emerging field of gas therapy has attracted extensive attention in the medical and scientific communities. Currently, considerable research has focused on the gasotransmitter nitric oxide (NO) owing to its unparalleled dual roles in directly killing cancer cells at high concentrations and cooperatively sensitizing cancer cells to other treatments for synergistic therapy. Of particular note, recent state-of-the-art studies have turned our attention to the chemical design of various endogenous/exogenous stimuli-responsive NO-releasing nanomedicines and their biomedical applications for on-demand NO-sensitized synergistic cancer therapy, which are discussed in this Minireview. Moreover, the potential challenges regarding NO gas therapy are also described, aiming to advance the development of NO nanomedicines as well as usher in new frontiers in this fertile research area.
Insights
Gas therapy utilizes nitric oxide (NO) for cancer treatment, either directly killing cells or enhancing other therapies. This review covers stimuli-responsive NO-releasing nanomedicines for synergistic cancer therapy.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Cancer Therapy
Background:
- Gas therapy, particularly using nitric oxide (NO), is a rapidly growing field due to its biocompatibility.
- Nitric oxide (NO) exhibits dual roles in cancer treatment: direct cytotoxicity at high concentrations and sensitization of cancer cells for synergistic therapy.
Purpose of the Study:
- To review the chemical design and biomedical applications of stimuli-responsive NO-releasing nanomedicines.
- To discuss the use of these nanomedicines for on-demand, NO-sensitized synergistic cancer therapy.
Main Methods:
- Review of recent state-of-the-art studies on NO-releasing nanomedicines.
- Analysis of endogenous/exogenous stimuli-responsive designs.
- Discussion of biomedical applications in synergistic cancer therapy.
Main Results:
- Emerging nanomedicines offer on-demand NO release for targeted cancer therapy.
- Stimuli-responsive designs enhance the efficacy of NO-based synergistic treatments.
- Significant advancements in chemical design for biomedical applications.
Conclusions:
- NO-releasing nanomedicines represent a promising frontier in synergistic cancer therapy.
- Further research into potential challenges is needed to advance NO gas therapy.
- Development of novel NO nanomedicines can lead to new therapeutic strategies.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gas Exchange and Transport
Responses to Drought and Flooding
Kinetic Molecular Theory and Gas Laws Explain Properties of Gas Molecules

